Get the latest Science News and Discoveries

How GLP-1 drugs like Ozempic and Wegovy affect risk of 175 conditions


The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an assessment of how the drugs affect 175 conditions

None

Get the Android app

Or read this on New Scientist

Read more on:

Photo of GLP-1 drugs

GLP-1 drugs

Photo of Risk

Risk

Photo of GLP-1

GLP-1

Related news:

News photo

Fatty muscles increase the risk of heart disease. Research shows that people with hidden fat in their muscles have a higher risk of death or hospitalization for heart attack or heart failure, regardless of their body mass index.

News photo

Scientists Warn: Your Home Temperature Could Be Increasing Your Risk of Cognitive Decline

News photo

97 Million People at Risk: Unregulated Toxins Found in U.S. Drinking Water